Tech Company Financing Transactions
Respira Labs Funding Round
Zentynel Frontier Investments, ImpactAssets and National Institutes of Health participated in a $2.8 million funding round for Respira Labs. The round was announced on 2/23/2022.
Transaction Overview
Company Name
Announced On
2/23/2022
Transaction Type
Venture Equity
Amount
$2,800,000
Round
Undisclosed
Investors
Zentynel Frontier Investments (Lead Investor) (Cristian Hernández-Cuevas)
Proceeds Purpose
In addition to the funding, Respira has been growing its product development -- something the funding will further accelerate.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
555 San Antonio Rd. 515
Mountain View, CA 94040
USA
Mountain View, CA 94040
USA
Phone
Undisclosed
Website
Email Address
Overview
Respira Labs' mission is to prevent and ultimately eliminate respiratory disease by empowering patients and clinicians with high quality,home-based actionable health information.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Maria Artunduaga
Browse more venture capital transactions:
Prev: 2/23/2022: Deepdub venture capital transaction
Next: 2/23/2022: Seyna venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions on this site come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs